This is one of the most common questions patients ask when starting these therapies for type 2 diabetes or weight management
Place Your Pharmacy Order Select your medicine (Ozempic, Wegovy, Rybelsus, Mounjaro, or liraglutide)
This is achieved through the activation of GLP-1 receptors, which play a vital role in controlling appetite and food intake
Its also convenient, affordable, and versatile
This medication was shown to reduce the risk of CKD progression and renal failure, as well as dialysis initiation, in the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease trial, which involved participants with type 2 diabetes who had albuminuria and advanced CKD
Exenatide: Least Effective Option Byetta, known by its generic name, Exenatide, is acknowledged as the GLP-1 receptor agonist with the lowest efficacy for aiding in weight loss